The latest closing stock price for Xeris Biopharma Holdings as of May 02, 2025 is 4.71.
An investor who bought $1,000 worth of Xeris Biopharma Holdings stock at the IPO in 2018 would have $-767 today, roughly -1 times their original investment - a -18.79% compound annual growth rate over 7 years.
The all-time high Xeris Biopharma Holdings stock closing price was 27.23 on September 10, 2018.
The Xeris Biopharma Holdings 52-week high stock price is 6.07, which is 28.9% above the current share price.
The Xeris Biopharma Holdings 52-week low stock price is 1.72, which is 63.5% below the current share price.
The average Xeris Biopharma Holdings stock price for the last 52 weeks is 3.18.
An investor who bought $1,000 worth of Xeris Biopharma Holdings stock at the IPO in 2018 would have $-767 today, roughly -1 times their original investment - a -18.79% compound annual growth rate over 7 years.
The all-time high Xeris Biopharma Holdings stock closing price was 27.23 on September 10, 2018.
The Xeris Biopharma Holdings 52-week high stock price is 6.07, which is 28.9% above the current share price.
The Xeris Biopharma Holdings 52-week low stock price is 1.72, which is 63.5% below the current share price.
The average Xeris Biopharma Holdings stock price for the last 52 weeks is 3.18.